1
项与 68Ga-NOTA-PEG2-RM26 相关的临床试验68Ga-NOTA-PEG2-RM26 PET/CT: Tracer Biodistribution and Uptake in Different Kinds of Cancer With Gastrin-Releasing Peptide Receptor (GRPR) Overexpression
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluation efficacy of 68Ga-NOTA-PEG2-RM26 in prostate cancer patients. A single dose of 2 MBq/kg of 68Ga-NOTA-PEG2-RM26 limited to 100-200 MBq per examination will be given intravenously. Visual and semiquantitative method will be used to assess PET/CT images.
100 项与 68Ga-NOTA-PEG2-RM26 相关的临床结果
100 项与 68Ga-NOTA-PEG2-RM26 相关的转化医学
100 项与 68Ga-NOTA-PEG2-RM26 相关的专利(医药)
100 项与 68Ga-NOTA-PEG2-RM26 相关的药物交易